ECOG-ACRIN Research at ASCO 2020

Researchers with the ECOG-ACRIN Cancer Research Group will present a wide range of research findings at the annual meeting of the American Society of Clinical Oncology (ASCO), occurring virtually May 29-31. The presentations include late-breaking data in two plenary sessions and several oral abstract presentations. Read the press release.

One of the oral abstract presentations will feature the results of E3311, a randomized phase II trial that showed transoral robotic surgery followed by low-dose radiation alone led to very good outcomes, similar to surgery with standard-dose radiation, in patients with HPV-positive throat cancer. Study chair Robert L. Ferris, MD, PhD (UPMC Hillman Cancer Center) will share the findings as the first presentation in the Head and Neck Oral Abstract Session. Read the press release.

EA Members Receive FASCO Distinction

Several ECOG-ACRIN members are receiving the Fellow of the American Society of Clinical Oncology (FASCO) distinction in 2020. The award recognizes individuals for their extraordinary volunteer service, dedication, and commitment to ASCO. Recipients include:

• David Paul Carbone, MD, PhD, FASCO
  Ohio State University
• Anne C. Chiang, MD, PhD, FASCO
  Yale University
• Kathy Miller, MD, FASCO
  Indiana University
• Nathan A. Pennell, MD, PhD, FASCO
  Cleveland Clinic Foundation
• Brian I. Rini, FASCO, MD
  Vanderbilt University
• Mark E. Robson, MD, FASCO
  Memorial Sloan Kettering Cancer Center
• Gabrielle Betty Rocque, MD, MSPH, FASCO
  University of Alabama
• Vered Stearns, MD, FASCO
  Johns Hopkins University
• Jeremy Lyle Warner, MD, MS, FASCO
  Vanderbilt University

Travel to the Fall 2020 Group Meeting

At this time, ECOG-ACRIN still plans to host its in-person Fall 2020 Group Meeting in Fort Lauderdale, Florida from Wednesday, October 21 – Friday, October 23. However, due to the evolving and unpredictable nature of the COVID-19 pandemic, please be sure to choose the most flexible option when booking travel so that you may cancel, if needed, without penalty. Any changes to the status of the Fall Group Meeting will be relayed in a timely manner. Thank you for your understanding as we navigate this challenging situation.

EA Leaders on the Move

Rathan M. Subramaniam, MD, PhD, MPH, formerly of UT Southwestern Medical Center, became dean of the medical school at the University of Otago (New Zealand) in February. He retains his roles within EA as chair of the Quantitative Imaging Working Group and imaging chair of the Head and Neck Cancer Committee. Learn more.

Lale Kostakoglu, MD, MPH left her position at Mount Sinai to become director of the Division of Nuclear Medicine at the University of Virginia. At EA, she serves as imaging chair of three committees: Leukemia, Lymphoma, and Myeloma.

Susanna I. Lee, MD, PhD of Massachusetts General Hospital has resigned as co-chair of the Gynecologic Cancer Working Group.